" class="no-js "lang="en-US"> Fundraising Archives - Page 33 of 41 - Medtech Alert
Monday, October 20, 2025

Sort by:

Date

Top Post

Novalis Biotech Invests in Ultra Sensitive Genomics Technology by Rarity Bioscience

Rarity Bioscience announces a new strategic investment from Belgium-based Novalis Biotech. The investment is facilitated […]

London Femtech Vira Health Scores £1.5M Seed Funding for Helping Women Cope with Menopause

The news is just in that Vira Health has raised £1.5 million in a seed […]

3D Printing Transforming Medical Implants: 4D Biomaterials Picks Up £1.6M Funding

A medtech company based in Nottingham, 4D Biomaterials, which has developed a new biomaterial used for […]

Aristea Completes $63 Million Series B Financing to Accelerate Clinical Development of Novel Immunotherapy Drugs for the Treatment of Orphan Diseases

Aristea Therapeutics (Aristea), a clinical-stage immunology focused drug development company developing novel therapies to treat […]

ScreenPoint Raises $28M in Series C Funding Led by Global ScaleUp Investor Insight Partners

Netherlands-based ScreenPoint Medical, an AI technology company that develops advanced image recognition and machine learning […]

Meet Peppy: London-based Women’s Health App Raises £6.6M to Directly Link Females with Specialists

Peppy, a B2B digital health platform, has announced a £6.6M Series A funding round led […]

Lumira Ventures Closes on US$255 Million of New Capital to Build Transformative Healthcare Companies

Lumira Ventures today announced a significant expansion of its capital base to support the founding […]

Novo Holdings Co-leads Hemab's US$ 55M Series A to Advance Next Generation Therapeutics for Bleeding and Thrombosis Disorders

Novo Holdings, a leading international life science investor, today announces that it has co-led alongside […]

Coave Therapeutics Closes €33 million ($39 million) Series B Financing to Develop its Gene Therapy Pipeline and Next-Generation Vectors based on its AAV-Ligand Conjugate Platform

Coave Therapeutics (pronounced ‘cove’; formerly Horama), a clinical stage biotechnology company focused on developing life […]

Panakès Partners Announces the First Closing of its New 'Purple' Global Biotech/Medtech Fund at €150 Million ($180 Million)

Panakès Partners, the leading Italian venture capital firm in the Life Sciences sector, announces the […]

NHS England Announces New Innovative Medicines Fund to Fast-track Promising New Drugs

NHS patients are set to benefit from early access to potentially life-saving new medicines, including cutting-edge gene therapies, […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more